Abstract
Although novel retroviral vectors for use in gene-therapy products are reducing the potential for formation of replication-competent retrovirus (RCR), it remains crucial to screen products for RCR for both research and clinical purposes. For clinical-grade gammaretrovirus-based vectors, RCR screening is achieved by an extended S+L− or marker-rescue assay, whereas standard methods for replication-competent lentivirus detection are still in development. In this report, we describe a rapid and sensitive method for replication-competent gammaretrovirus detection. We used this assay to detect three members of the gammaretrovirus family and compared the sensitivity of our assay with well-established methods for retrovirus detection, including the extended S+L− assay. Results presented here demonstrate that this assay should be useful for gene-therapy product testing.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R et al. Gene transfer into humans—immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 1990; 323: 570–578.
Chong H, Starkey W, Vile RG . A replication-competent retrovirus arising from a split-function packaging cell line was generated by recombination events between the vector, one of the packaging constructs, and endogenous retroviral sequences. J Virol 1998; 72: 2663–2670.
Garrett E, Miller AR, Goldman JM, Apperley JF, Melo JV . Characterization of recombination events leading to the production of an ecotropic replication-competent retrovirus in a GP+envAM12-derived producer cell line. Virology 2000; 266: 170–179.
Patience C, Takeuch Y, Cosset FL, Weiss RA . MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency. Dev Biol (Basel) 2001; 106: 169–179; discussion 253–263.
Sfanos KS, Aloia AL, Hicks JL, Esopi DM, Steranka JP, Shao W et al. Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines. PLoS One 2011; 6: e20874.
Cornetta K, Nguyen N, Morgan RA, Muenchau DD, Hartley JW, Blaese RM et al. Infection of human cells with murine amphotropic replication-competent retroviruses. Hum Gene Ther 1993; 4: 579–588.
Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992; 176: 1125–1135.
US Food and Drug Administration. Guidance for Industry. Supplemental Guidance for Testing for Replication Competent Retrovirus in Retroviral Vector Based Gene Therapy Products and During Follow-Up of Patients in Clinical Trials using Retroviral Vectors, 2006 (www.fda.gov/OHRMS/DOCKETS/98fr/994114gd.pdf).
Cornetta K, Wilson CA . Safety of retroviral vectors: regulatory and technical considerations. In: Dropulic B, Carter B (eds). Concepts in Genetic Medicine. John-Liss: Hoboken, NJ, 2008, pp 277–288.
Bassin RH, Tuttle N, Fischinger PJ . Rapid cell culture assay technique for murine leukaemia viruses. Nature 1971; 229: 564–566.
Dorjbal B, Derse D, Lloyd P, Soheilian F, Nagashima K, Heidecker G . The role of ITCH in human T-cell leukemia virus type 1 release. J Biol Chem 2011; 286: 31092–31104.
Mazurov D, Ilinskaya A, Heidecker G, Lloyd P, Derse D . Quantitative comparison of HTLV-1 and HIV-1 cell-to-cell infection with new replication dependent vectors. PLoS Pathogen 2010; 6: e1000788.
Albritton LM, Tseng L, Scadden D, Cunningham JM . A putative murine ecotropic retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 1989; 57: 659–666.
Tannous BA, Kim DE, Fernandez JL, Weissleder R, Breakefield XO . Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther 2005; 11: 435–443.
Verhaegent M, Christopoulos TK . Recombinant Gaussia luciferase. Overexpression, purification, and analytical application of a bioluminescent reporter for DNA hybridization. Anal Chem 2002; 74: 4378–4385.
Curcio MJ, Garfinkel DJ . Single-step selection for Ty1 element retrotransposition. Proc Natl Acad Sci USA 1991; 88: 936–940.
Heidmann O, Heidmann T . Retrotransposition of a mouse IAP sequence tagged with an indicator gene. Cell 1991; 64: 159–170.
Heidmann T, Heidmann O, Nicolas JF . An indicator gene to demonstrate intracellular transposition of defective retroviruses. Proc Natl Acad Sci USA 1988; 85: 2219–2223.
Chen J, Reeves L, Sanburn N, Croop J, Williams DA, Cornetta K . Packaging cell line DNA contamination of vector supernatants: implication for laboratory and clinical research. Virology 2001; 282: 186–197.
Chen J, Reeves L, Cornetta K . Safety testing for replication-competent retrovirus associated with gibbon ape leukemia virus-pseudotyped retroviral vectors. Hum Gene Ther 2001; 12: 61–70.
Printz M, Reynolds J, Mento SJ, Jolly D, Kowal K, Sajjadi N . Recombinant retroviral vector interferes with the detection of amphotropic replication competent retrovirus in standard culture assays. Gene Therapy 1995; 2: 143–150.
Sastry L, Cornetta K . Detection of replication competent retrovirus and lentivirus. Methods Mol Biol 2009; 506: 243–263.
Knouf EC, Metzger MJ, Mitchell PS, Arroyo JD, Chevillet JR, Tewari M et al. Multiple integrated copies and high-level production of the human retrovirus XMRV (xenotropic murine leukemia virus-related virus) from 22Rv1 prostate carcinoma cells. J Virol 2009; 83: 7353–7356.
Morner A, Bjorndal A, Albert J, Kewalramani VN, Littman DR, Inoue R et al. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol 1999; 73: 2343–2349.
Morgenstern JP, Land H . A series of mammalian expression vectors and characterisation of their expression of a reporter gene in stably and transiently transfected cells. Nucleic Acids Res 1990; 18: 1068.
Rein A . Interference grouping of murine leukemia viruses: a distinct receptor for the MCF-recombinant viruses in mouse cells. Virology 1982; 120: 251–257.
Sanburn N, Cornetta K . Rapid titer determination using quantitative real-time PCR. Gene Therapy 1999; 6: 1340–1345.
Aloia AL, Sfanos KS, Isaacs WB, Zheng Q, Maldarelli F, De Marzo AM et al. XMRV: a new virus in prostate cancer? Cancer Res 2010; 70: 10028–10033.
Acknowledgements
We thank Jane Mirro, Gerry Princler, Patricia Lloyd and Shawn Hill for superb technical assistance, and Vineet KewalRamani for many helpful discussions. This work was supported in part by the Intramural Research Program of the NIH, National Cancer Institute and Center for Cancer Research. Work at Indiana University is supported by the NIH, National Center for Research Resource (National Gene Vector Biorepository P40 RR024928).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Aloia, A., Duffy, L., Pak, V. et al. A reporter system for replication-competent gammaretroviruses: the inGluc-MLV-DERSE assay. Gene Ther 20, 169–176 (2013). https://doi.org/10.1038/gt.2012.18
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/gt.2012.18